Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis

Bibliographic Details
Main Authors:	Davì S, Lanni S, Solari N, Magni-Manzoni S, Consolaro A, Schiappapietra B, Pederzoli S, Bracciolini G, Martini A, Ravelli A
Format:	Article
Language:	English
Published:	BMC 2011-09-01
Series:	Pediatric Rheumatology Online Journal

Similar Items

A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis
by: Cecilia Bava, et al.
Published: (2019-07-01)

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)
by: Davì S, et al.
Published: (2008-09-01)

A new approach to defining inactive disease, minimal disease activity and parent- and child-acceptable symptom state in juvenile idiopathic arthritis
by: Bertamino M, et al.
Published: (2011-09-01)

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)
by: Filocamo G, et al.
Published: (2008-09-01)

IL-1 inhibition in systemic juvenile idiopathic arthritis
by: Gabriella Giancane, et al.
Published: (2016-12-01)

Inactive disease and remission rates after intraarticular steroids as initial therapy for juvenile idiopathic arhtritis (JIA)
by: Brito RG, et al.
Published: (2011-09-01)

Evaluation of the power of six clustering features in identifying a homogeneous disease subset in juvenile idiopathic arthritis (JIA)
by: Magnani A, et al.
Published: (2008-09-01)

Children with juvenile idiopathic arthritis currently followed in a tertiary care setting have a better psychosocial well-being than healthy peers
by: Suffia C, et al.
Published: (2011-09-01)

Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
by: Consolaro A, et al.
Published: (2008-09-01)

Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE)
by: Espada Graciela, et al.
Published: (2011-09-01)

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)
by: Dalprà S, et al.
Published: (2008-09-01)

IL-6 blockade in systemic juvenile idiopathic arthritis – achievement of inactive disease and remission (data from the German AID-registry)
by: M. Bielak, et al.
Published: (2018-04-01)

The PRINTO provisional definition of remission in juvenile dermatomyositis
by: Kasapcopur O, et al.
Published: (2011-09-01)

Preliminary validation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 403 clinic patients
by: Solari N, et al.
Published: (2008-09-01)

Impaired Muscular Fat Metabolism in Juvenile Idiopathic Arthritis in Inactive Disease
by: Emmanuelle Rochette, et al.
Published: (2019-05-01)

Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis
by: Meiorin S, et al.
Published: (2008-09-01)

Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis
by: Buoncompagni Antonella, et al.
Published: (2007-12-01)

Do parent's global rating of well-being and disease activity of children with juvenile idiopathic arthritis yield different information?
by: Ullmann N, et al.
Published: (2008-09-01)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
by: Verazza S, et al.
Published: (2008-09-01)

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)
by: Lattanzi B, et al.
Published: (2008-09-01)

Consenso em reumatologia pediátrica: parte I - definição dos critérios de doença inativa e remissão em artrite idiopática juvenil/artrite reumatóide juvenil Consensus in pediatric rheumatology: part I - criteria definition of inactive disease and remission in juvenile idiopathic arthritis / juvenile rheumatoid arthritis
by: Claudia Machado, et al.
Published: (2005-02-01)

Can remission be in juvenile idiopathic arthritis without the use of biological agents?
by: S. I. Valieva, et al.
Published: (2019-09-01)

MRI evaluation of clinical remission in juvenile idiopathic arthritis
by: van Rossum MAJ, et al.
Published: (2011-09-01)

Treatment of idiopathic light chain deposition disease: complete remission with bortezomib and dexamethasone
by: João Tadeu Damian Souto Filho, et al.

Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
by: Gabriella Giancane, et al.
Published: (2019-07-01)

Complete remission of nephrotic syndrome secondary to amyloid a amyloidosis in patient with inactive Crohn's disease after treatment by infliximab
by: Kawtar Hassani, et al.
Published: (2018-01-01)

Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease
by: Rachel A. Brown, et al.
Published: (2018-12-01)

Duration of inactive disease while off disease-modifying anti-rheumatic drugs seems to influence flare rates in juvenile idiopathic arthritis: an observational retrospective study
by: Patricia Patricia Aires, et al.
Published: (2021-04-01)

Multisystem Inflammatory Syndrome in Children: Unique Disease or Part of the Kawasaki Disease Spectrum?
by: Caterina Matucci-Cerinic, et al.
Published: (2021-06-01)

Development and initial validation of a new short and simple Health-Related Quality Of Life (HRQL) Questionnaire for Pediatric Rheumatic Diseases (PRD)
by: Palmisani E, et al.
Published: (2008-09-01)

Discontinuation of etanercept after clinical remission in patients with juvenile idiopathic arthritis
by: Cohen Jean-David, et al.
Published: (2012-07-01)

Remission and Active Disease in Young Adult Patients with Juvenile Idiopathic Arthritis During the Transition Period from Paediatric to Adult Healthcare
by: Marta Dzhus
Published: (2018-09-01)

Inactivity and fatty liver disease
by: Marek Rác, et al.
Published: (2016-12-01)

Articular Doppler ultrasonography in juvenile idiopathic arthritis in remission: a prospective study
by: Natour Jamil, et al.
Published: (2011-09-01)

Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission
by: Inmaculada Concepción Aranda-Valera, et al.
Published: (2020-07-01)

Strategies for the withdrawal of classic and biological DMARD in clinically inactive patients with juvenile idiopathic arthritis
by: Soraia Azevedo Azevedo, et al.
Published: (2020-07-01)

Macedonian constitutional court and the Prespa agreement unbearable ease of inactivity
by: Tanja KARAKAMISHEVA-JOVANOVSKA, et al.
Published: (2021-06-01)

Remission in cushing disease with cabergoline
by: Gopal Raju, et al.
Published: (2008-01-01)

MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?
by: Viola S, et al.
Published: (2011-09-01)

MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?
by: Viola S, et al.
Published: (2011-09-01)